CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)		12 Months Ended
		Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016
Cash flows from operating activities:
Net loss		$ (319,900,000)		$ (295,600,000)		$ (76,700,000)
Net (loss) income from discontinued operations, net of tax		(242,900,000)		(103,800,000)		113,800,000
Net loss from continuing operations		(77,000,000.0)		(191,800,000)		(190,500,000)
Reconciliations of net loss to net cash flows provided by operating activities:
Depreciation and amortization		156,700,000		156,000,000.0		155,700,000
Deferred income taxes		(54,700,000)		(134,100,000)		(42,400,000)
Amortization of inventory step-up		0		0		11,700,000
Foreign exchange (gain) loss		(200,000)		45,800,000		34,000,000.0
Goodwill impairment		0		0		46,600,000
Gain on settlement agreement related to Series B Convertible Preferred Stock		0		0		(103,000,000.0)
Other, net		4,000,000.0		75,100,000		67,900,000
Changes in assets and liabilities, net of acquisitions:
Accounts receivable		900,000		(21,500,000)		(42,400,000)
Inventory		(18,800,000)		(9,200,000)		7,600,000
Accounts payable		(5,500,000)		(3,300,000)		(9,200,000)
Accrued expenses		(10,600,000)		2,500,000		26,500,000
Prepaid expenses and other current assets		10,500,000		(13,000,000.0)		(4,300,000)
Other assets and liabilities		(6,100,000)		59,200,000		3,800,000
Net cash flows used in operating activities of continuing operations		(800,000)		(34,300,000)		(38,000,000.0)
Cash flows from investing activities:
Capital expenditures		(28,400,000)		(30,800,000)		(32,600,000)
Proceeds from disposal of property, plant and equipment		4,200,000		16,900,000		9,400,000
Proceeds from the sale of equity investment		25,000,000.0		0		0
Acquisition of business, net of cash acquired		(28,200,000)		0		(1,200,000)
Other, net		3,600,000		(5,000,000.0)		(1,700,000)
Net cash flows used in investing activities of continuing operations		(23,800,000)		(18,900,000)		(26,100,000)
Cash flows from financing activities:
Debt proceeds, net of discount and premium		0		4,142,700,000		3,300,900,000
Repayments of borrowings		(22,500,000)		(4,122,500,000)		(3,339,600,000)
Change in lines of credit, net		25,000,000.0		0		(13,200,000)
Proceeds from issuance of common stock, net		1,400,000		1,400,000		391,500,000
Payment of financing fees		(1,400,000)		(22,600,000)		(9,500,000)
Settlement of Series B Convertible Preferred Stock		0		0		(460,000,000.0)
Other, net		(3,900,000)		(700,000)		(600,000)
Net cash flows used in financing activities of continuing operations		(1,400,000)		(1,700,000)		(130,500,000)
Cash flows from discontinued operations:
Net cash flows (used in) provided by operating activities of discontinued operations		(7,900,000)		185,300,000		227,800,000
Net cash flows used in investing activities of discontinued operations		(51,200,000)		(28,600,000)		(44,700,000)
Net cash flows provided by (used in) financing activities of discontinued operations		43,800,000		(74,500,000)		19,900,000
Net cash flows (used in) provided by discontinued operations		(15,300,000)		82,200,000		203,000,000.0
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(27,000,000.0)		33,100,000		(17,500,000)
Net (decrease) increase in cash, cash equivalents and restricted cash		(68,300,000)		60,400,000		(9,100,000)
Cash, cash equivalents and restricted cash at beginning of period	[2]	483,800,000	[1]	423,400,000	[1]	432,500,000
Cash, cash equivalents and restricted cash at end of period	[1]	415,500,000		483,800,000	[2]	423,400,000	[2]
Continuing Operations
Supplemental disclosure information of continuing operations:
Cash paid for interest		293,400,000		315,700,000		348,800,000
Cash paid for income taxes		$ 78,900,000		$ 73,900,000		$ 62,600,000

[1] Includes cash, cash equivalents and restricted cash of discontinued operations of $181.9 million, $225.4 million and $187.4 million at December 31, 2018, 2017 and 2016, respectively.

[2] Includes cash, cash equivalents and restricted cash of discontinued operations of $225.4 million, $187.4 million and $255.7 million at December 31, 2017, 2016 and 2015, respectively.